Neolys Diagnostics

About:

Neolys develops efficient solutions to help clinicians to adapt treatment to individual radiosensitivity of each patient: Precision Medicine

Website: http://www.neolysdiagnostics.com/fr/

Twitter/X: NeolysDiag

Top Investors: Eurostars

Description:

Dedicated to bringing precision medicine in radiotherapy, Neolys Diagnostics, a Lyon (France) based company, develops innovative and efficient solutions to improve patients’ outcome and treatments,. It proposes efficient solutions for decision-making tool to radiation oncologists, allowing them to adapt treatment as per radiosensitivity of individual patient. This helps in reducing side effects while optimizing the treatment efficiency.

Total Funding Amount:

2.04M EUR

Headquarters Location:

Lyon, Rhone-Alpes, France

Founded Date:

2014-01-01

Contact Email:

contact(AT)neolysdiagnostics.com

Founders:

Gilles Devillers, Julien Gillet Daubin, Nicolas Foray

Number of Employees:

1-10

Last Funding Date:

2017-04-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai